Tissue plasminogen activator (tPA) is a serine protease that induces the conversion of plasminogen to plasmin to dissolve fibrin-based blood clots and is routinely used in ischemic stroke pharmacotherapy [7, 8]. This evidence concerns the gene PLAT and ischemic stroke.